Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Respiratory and ...
Early application of prone positioning did not help patients with severe acute respiratory distress syndrome (ARDS) -- mostly from COVID -- get off venovenous extracorporeal membrane oxygenation ...
Please provide your email address to receive an email when new articles are posted on . A high effort to eliminate carbon dioxide was linked to a greater likelihood of failing to wean from venovenous ...
Packed red blood cell transfusion improved survival among adults with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation when using a hemoglobin threshold of less ...
(UPDATED) In the race to save lives, physicians have turned to extracorporeal membrane oxygenation (ECMO) and, more rarely, other forms of mechanical circulatory support (MCS) to overcome lung and ...
A notable proportion of patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure developed acute kidney injury (AKI), likely due to the greater severity ...
Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with 'meaningful' long-term ...
(HealthDay)—Extracorporeal membrane oxygenation (ECMO) support might improve clinical outcomes in severe cases of coronavirus disease 2019 (COVID-19) that cannot be adequately managed with mechanical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results